These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy. Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP Elife; 2023 Feb; 12():. PubMed ID: 36723429 [TBL] [Abstract][Full Text] [Related]
3. POMK regulates dystroglycan function via LARGE1-mediated elongation of matriglycan. Walimbe AS; Okuma H; Joseph S; Yang T; Yonekawa T; Hord JM; Venzke D; Anderson ME; Torelli S; Manzur A; Devereaux M; Cuellar M; Prouty S; Ocampo Landa S; Yu L; Xiao J; Dixon JE; Muntoni F; Campbell KP Elife; 2020 Sep; 9():. PubMed ID: 32975514 [TBL] [Abstract][Full Text] [Related]
4. Altered expression of natively glycosylated alpha dystroglycan in pediatric solid tumors. Martin LT; Glass M; Dosunmu E; Martin PT Hum Pathol; 2007 Nov; 38(11):1657-68. PubMed ID: 17640712 [TBL] [Abstract][Full Text] [Related]
5. HNK-1 sulfotransferase modulates α-dystroglycan glycosylation by 3-O-sulfation of glucuronic acid on matriglycan. Sheikh MO; Venzke D; Anderson ME; Yoshida-Moriguchi T; Glushka JN; Nairn AV; Galizzi M; Moremen KW; Campbell KP; Wells L Glycobiology; 2020 Sep; 30(10):817-829. PubMed ID: 32149355 [TBL] [Abstract][Full Text] [Related]
6. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822 [TBL] [Abstract][Full Text] [Related]
7. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726 [TBL] [Abstract][Full Text] [Related]
8. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252 [TBL] [Abstract][Full Text] [Related]
9. Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1. Righino B; Bozzi M; Pirolli D; Sciandra F; Bigotti MG; Brancaccio A; De Rosa MC J Chem Inf Model; 2020 Jun; 60(6):3145-3156. PubMed ID: 32356985 [TBL] [Abstract][Full Text] [Related]
10. Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts. Fernandez K; Serinagaoglu Y; Hammond S; Martin LT; Martin PT Am J Pathol; 2010 Jan; 176(1):416-34. PubMed ID: 20019182 [TBL] [Abstract][Full Text] [Related]
11. Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Inamori K; Yoshida-Moriguchi T; Hara Y; Anderson ME; Yu L; Campbell KP Science; 2012 Jan; 335(6064):93-6. PubMed ID: 22223806 [TBL] [Abstract][Full Text] [Related]
12. The inside and out of dystroglycan post-translational modification. Moore CJ; Winder SJ Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978 [TBL] [Abstract][Full Text] [Related]
13. A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α-dystroglycan. Kim J; Lana B; Torelli S; Ryan D; Catapano F; Ala P; Luft C; Stevens E; Konstantinidis E; Louzada S; Fu B; Paredes-Redondo A; Chan AE; Yang F; Stemple DL; Liu P; Ketteler R; Selwood DL; Muntoni F; Lin YY EMBO Rep; 2019 Nov; 20(11):e47967. PubMed ID: 31566294 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417 [TBL] [Abstract][Full Text] [Related]
16. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. Patnaik SK; Stanley P J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414 [TBL] [Abstract][Full Text] [Related]
17. Investigating the functions of LARGE: lessons from mutant mice. Hewitt JE Methods Enzymol; 2010; 479():367-86. PubMed ID: 20816177 [TBL] [Abstract][Full Text] [Related]
18. Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2. Mamsa H; Stark RL; Shin KM; Beedle AM; Crosbie RH Hum Mol Genet; 2022 Mar; 31(5):718-732. PubMed ID: 34581784 [TBL] [Abstract][Full Text] [Related]
19. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969 [TBL] [Abstract][Full Text] [Related]
20. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]